CYMABAY THERAPEUTICS

CymaBay Therapeutics is a clinical-stage biopharmaceutical company located in the San Francisco Bay Area focused on the development and commercialization of proprietary new medicines for important human diseases. We are committed to developing breakthrough medicines that improve the lives of patients and their families. CymaBay was seeded with the assets from an earlier metabolic disease company in which more than $120M was invested to produce a robust pipeline. Arhalofenate is a novel oral s... mall molecule being developed to treat the approximately 1 million gout patients that flare three or more times per year. Gout flares are painful inflammatory episodes caused by crystals of monosodium urate (MSU) that result from excess serum uric acid (sUA). In three Phase 2 studies in gout patients arhalofenate was shown to reduce the incidence and duration of flares while simultaneously lowering sUA. If confirmed in additional clinical studies, arhalofenate’s dual acting profile would be unique since all other urate lowering therapies paradoxically increase flares as they lower sUA over the first 6 to 12 months of treatment. Increased flares lead many patients to stop or avoid treatment leading to progression of disease with pain and suffering, erosion of joint structure and functionality, lost time from work, and increased healthcare costs.

#SimilarOrganizations #People #Financial #Website #More

CYMABAY THERAPEUTICS

Social Links:

Industry:

Biopharma Biotechnology Pharmaceutical

Founded:

1991-01-01

Address:

Hayward, California, United States

Country:

United States

Website Url:

http://www.cymabay.com

Total Employee:

51+

Status:

Active

Contact:

5102938800

Email Addresses:

[email protected]

Total Funding:

366.51 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Universal Analytics Domain Not Resolving Apache

Similar Organizations

acer-therapeutics-logo

Acer Therapeutics

Acer Therapeutics focuses on the acquisition, development, and commercialization of therapies for patients with serious rare diseases.

bexion-pharmaceuticals-logo

Bexion Pharmaceuticals

Bexion Pharmaceuticals is a privately-held biotech company focused on the development and commercialization of innovative cures for cancer.

biomarin-pharmaceutical-logo

BioMarin Pharmaceutical

BioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions.

castle-creek-biosciences-logo

Castle Creek Biosciences

Castle Creek Biosciences is focused on developing commercializing novel, personalized gene therapies for rare skin disorders.

crispr-therapeutics-logo

CRISPR Therapeutics

CRISPR Therapeutics is focused on the development of transformative medicines using its proprietary CRISPR/Cas9 gene-editing platform.

cyteir-therapeutics-logo

Cyteir Therapeutics

Cyteir is developing the next generation of synthetic lethal therapies to treat cancer.

athenex-logo

Athenex

Athenex is a biopharmaceutical company that develops and discovers novel therapies for treating cancer and related conditions.

lentigen-logo

Lentigen

Lentigen Corporation is engaged in the development and commercialization of gene delivery technologies for human diseases.

nirogy-therapeutics-logo

Nirogy Therapeutics

Nirogy Therapeutics is focusing on small-molecule drugs that target the solute carrier family of transporter proteins (SLCTs).

parexel-logo

PAREXEL

PAREXEL is a biopharmaceutical services company that focuses on the development and commercialization of new medical therapies worldwide.

bambu-global-logo

Bambu Global

Bambu Global focuses on developing and commercializing breakthrough scientific discoveries.

pliant-therapeutics-logo

Pliant Therapeutics

Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.

galectin-therapeutics-logo

Galectin Therapeutics

Galectin Therapeutics uses galectin science and drug development to create new therapies for fibrotic diseases and cancer.

eyepoint-pharmaceuticals-logo

EyePoint Pharmaceuticals

EyePoint Pharmaceuticals specializes in the development and commercialization of ophthalmic products for the treatment of eye diseases.

reata-pharmaceuticals-logo

Reata Pharmaceuticals

Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.

receptos-logo

Receptos

Receptos focuses on the discovery, development and commercialization of various therapeutics for immune disorders.

revive-therapeutics-logo

Revive Therapeutics

Revive Therapeutics is focused on the research, development and commercialization ofnovel therapies and technologies company.

sorrento-therapeutics-logo

Sorrento Therapeutics

Sorrento Therapeutics is focused on the development of proprietary drug therapeutics for addressing unmet medical needs.

sunshine-biopharma-logo

Sunshine Biopharma

Sunshine Biopharma focuses on the research, development, and commercialization of drugs for the treatment of various forms of cancer.

synta-pharmaceuticals-logo

Synta Pharmaceuticals

Synta Pharmaceuticals is focused on developing and commercializing small molecule drugs to treat cancer and chronic inflammatory diseases.

targimmune-therapeutics-logo

TargImmune Therapeutics

TargImmune Therapeutics is focused on drug development using novel targeted onco-immunotherapies.

uluru-logo

ULURU

ULURU engages in the research, development, and commercialization of wound care and mucoadhesive film products.

Current Advisors List

eric-converse_image

Eric Converse Board of Directors @ CymaBay Therapeutics
Board_member

kurt-von-emster_image

Kurt von Emster Board of Directors @ CymaBay Therapeutics
Board_member

robert-wills_image

Robert Wills Chairman of the Board @ CymaBay Therapeutics
Board_member
2015-10-01

ed-penhoet_image

Ed Penhoet Board of Directors @ CymaBay Therapeutics
Board_member

louis-lange_image

Louis Lange Member of the Board of Directors @ CymaBay Therapeutics
Board_member

kurt-von-emster_image

Kurt von Emster Board of Directors @ CymaBay Therapeutics
Board_member
2009-01-01

anthony-evnin_image

Anthony Evnin Board of Directors @ CymaBay Therapeutics
Board_member

carl-goldfischer_image

Carl Goldfischer Board of Directors @ CymaBay Therapeutics
Board_member

Current Employees Featured

charles-a-mcwherter_image

Charles A. McWherter
Charles A. McWherter SVP & Chief Scientific Officer @ CymaBay Therapeutics
SVP & Chief Scientific Officer
2007-07-01

becki-filice_image

Becki Filice
Becki Filice Senior Vice President, Portfolio and Product Leadership @ CymaBay Therapeutics
Senior Vice President, Portfolio and Product Leadership
2020-11-01

alexandra-steinberg_image

Alexandra Steinberg
Alexandra Steinberg Senior Medical Director @ CymaBay Therapeutics
Senior Medical Director
2020-01-01

not_available_image

Mary Jean Stempien
Mary Jean Stempien Acting Chief Medical Officer @ CymaBay Therapeutics
Acting Chief Medical Officer

ken-boehm_image

Ken Boehm
Ken Boehm Senior Vice President Human Resources @ CymaBay Therapeutics
Senior Vice President Human Resources
2020-01-01

jeff-stebbins_image

Jeff Stebbins
Jeff Stebbins Senior Director of Research Operations and Scientific Affairs @ CymaBay Therapeutics
Senior Director of Research Operations and Scientific Affairs
2018-01-01

dennis-kim_image